It promotes IL6 expression, and IL-6 promotes STAT3 phosphorylation, which activates the IL-6/STAT3 pathway and thus enhances the proliferation of hepatocellular carcinoma cells (25). The gene discussed is STAT3; the disease is hepatocellular carcinoma.